Data Transmission Vulnerability in Baxter Medical Devices
CVE-2020-12037

7.5HIGH

Key Information:

Vendor

Baxter

Status
Baxter Prismaflex And Prismax
Vendor
CVE Published:
29 June 2020

What is CVE-2020-12037?

The PrismaFlex and PrisMax systems by Baxter lack proper data-in-transit encryption. This absence of TLS/SSL when transmitting treatment data to external systems such as Patient Data Management Systems (PDMS) or Electronic Medical Records (EMR) exposes sensitive patient information. As a result, attackers could potentially intercept and observe critical health data during transmission, leading to serious privacy concerns and risks to patient confidentiality. This vulnerability highlights the need for encryption protocols to safeguard sensitive medical data as it travels across networks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Baxter PrismaFlex and PrisMax PrismaFlex all versions, PrisMax all versions prior to 3.x

References

https://www.us-cert.gov/ics/advisories/icsma-20-170-01
x_refsource_MISC

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.